Global Blood Therapeutics Inc: Istoricul versiunilor

1 octombrie 2024

• actualăprec 02:451 octombrie 2024 02:45‎ 127.0.0.1 discuție‎ 1.142 de octeți +4‎ The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles). anulare

18 septembrie 2024

• actualăprec 20:5818 septembrie 2024 20:58‎ Admin discuție contribuții‎ 1.138 de octeți +1.138‎ Pagină nouă: Pagina dedicata companiei Global Blood Therapeutics Inc listata cu simbolul US.GBT ==Descriere companie== Global Blood Therapeutics, Inc.(www.gbt.com) is a biopharmaceutical company that discovers, develops and delivers treatments. The company has introduced Oxbryta (voxelotor) tablets, the Food and Drug Administration (FDA) approved treatment that directly inhibits sickle hemoglobin polymerization, the root cause of red blood cell sickling in sickle cell disease (SCD). The...